Triazolopyridine derivatives as inhibitors of lipases and phospholipases

US7718669B2 · kind B2 · utility

Assignee

• Sanofi-Aventis · FR

Inventors

• Stefan Petry · Kelkheim, DE
• Gerhard Zoller · Blankenloch, DE
• Gunter Muller · Frankfurt am Main, DE
• Karl-Heinz Baringhaus · Blieskastel, DE
• Hubert Heuer · Frankfurt am Main, DE

Key dates

• Filing date: Apr 9, 2008
• Grant date: May 18, 2010
• Expiry date: Apr 9, 2028

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D487/04
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to triazolopyridine derivatives of general formula (I), which are defined as cited in the description, to their pharmaceutically applicable salts and to their use as medicaments.